Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Single-Center, Open-label, Controlled, Randomized Study to Evaluate the Safety and Immunogenicity of Novartis Men ACWY Vaccine Administered Either Alone or Concomitantly With a Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine and Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine in Healthy Adolescents
Brief Summary: This study will evaluate the safety and immune response of the Novartis Meningococcal ACWY conjugate vaccine when administered with Tdap and HPV vaccinations to healthy adolescents


Options:
A: Arm Label: MenACWY + Tdap + HPV; Type: EXPERIMENTAL; Interventions: Biological: Novartis Meningococcal ACWY Conjugate Vaccine | Arm Label: MenACWY →Tdap → HPV; Type: EXPERIMENTAL; Interventions: Biological: Novartis Meningococcal ACWY Conjugate Vaccine | Arm Label: Tdap →MenACWY → HPV; Type: EXPERIMENTAL; Interventions: Biological: Tdap Vaccine | Intervention Type: BIOLOGICAL; Name: Novartis Meningococcal ACWY Conjugate Vaccine; Assigned to Arm(s): MenACWY + Tdap + HPV | Intervention Type: BIOLOGICAL; Name: Tdap Vaccine; Assigned to Arm(s): Tdap →MenACWY → HPV | Intervention Type: BIOLOGICAL; Name: Novartis Meningococcal ACWY Conjugate Vaccine; Assigned to Arm(s): MenACWY →Tdap → HPV
B: Arm Label: Cervarix Group; Type: EXPERIMENTAL; Interventions: Procedure: Blood sampling, Procedure: Collection of cervical specimen, Biological: Cervarix | Arm Label: Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Blood sampling, Procedure: Collection of cervical specimen | Intervention Type: PROCEDURE; Name: Blood sampling; Assigned to Arm(s): Cervarix Group, Placebo Group | Intervention Type: PROCEDURE; Name: Collection of cervical specimen; Assigned to Arm(s): Cervarix Group, Placebo Group | Intervention Type: BIOLOGICAL; Name: Cervarix; Assigned to Arm(s): Cervarix Group
C: Arm Label: 3-dose; Type: ACTIVE_COMPARATOR; Interventions: Biological: Prophylactic quadrivalent HPV vaccine Merck (Gardasil®) | Arm Label: 2-dose; Type: EXPERIMENTAL; Interventions: Biological: Prophylactic quadrivalent HPV vaccine Merck (Gardasil®) | Arm Label: 2 doses by default; Type: EXPERIMENTAL; Interventions: Biological: Prophylactic quadrivalent HPV vaccine Merck (Gardasil®) | Arm Label: Single-dose; Type: EXPERIMENTAL; Interventions: Biological: Prophylactic quadrivalent HPV vaccine Merck (Gardasil®) | Arm Label: Unvaccinated; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BIOLOGICAL; Name: Prophylactic quadrivalent HPV vaccine Merck (Gardasil®); Assigned to Arm(s): 2 doses by default, 2-dose, 3-dose, Single-dose
D: Arm Label: 9- to 15-Year-Old Females (Lot 1); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 9- to 15-Year-Old Females (Lot 2); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 9- to 15-Year-Old Females (Lot 3); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 9- to 15-Year-Old Males (Lot 1); Type: EXPERIMENTAL; Interventions: Biological: V503 | Arm Label: 16- to 26-Year-Old Females (Lot 1); Type: EXPERIMENTAL; Interventions: Biological: V503 | Intervention Type: BIOLOGICAL; Name: V503; Assigned to Arm(s): 16- to 26-Year-Old Females (Lot 1), 9- to 15-Year-Old Females (Lot 1), 9- to 15-Year-Old Females (Lot 2), 9- to 15-Year-Old Females (Lot 3), 9- to 15-Year-Old Males (Lot 1)

Answer: A